FTC Accuses Electronic Prescription Co. Of Monopolization

Law360 (April 24, 2019, 6:26 PM EDT) -- The Federal Trade Commission said Wednesday that it has sued Surescripts in D.C. federal court over allegations that the company uses contract terms and other tactics to illegally maintain its monopoly over electronic prescription services.

The FTC filed a sealed complaint April 17 accusing Surescripts LLC of using exclusive agreements, loyalty payments and threats to preserve its 95% share in two markets related to the provision of electronic prescription services, which allow health care providers to electronically transmit prescriptions to pharmacies.

Bruce Hoffman, director of the FTC’s bureau of competition, said in a statement Wednesday that the company’s efforts successfully thwarted...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS